External Source

Hurdles To Car-t Therapy For Mds & Aml: T-cell Fitness & Lack Of A Uniform Target Antigen

2023 1:16
Synopsis
David Sallman, MD, Moffitt Cancer Center, Tampa, FL, outlines the current challenges in bringing CAR-T therapies to myeloid ...

You Might Also Like

CAR T Cell Therapy in MDS/AML 1:31:25
Car T Cell Therapy In Mds/aml
2021
Mechanisms of resistance to CAR-T in ALL: T-cell fitness, antigen loss and immunological rejection 3:38
Mechanisms Of Resistance To Car-t In All: T-cell Fitness, An...
2023
CAR T-Cell Therapy: How Does It Work? 2:21
Car T-cell Therapy: How Does It Work?
2017
Challenges in developing CAR-T therapy for AML 1:44
Challenges In Developing Car-t Therapy For Aml
2022
Future prospects for CAR-T cell therapy in AML 2:11
Future Prospects For Car-t Cell Therapy In Aml
2022
Key challenges in immunotherapy for AML 1:12
Key Challenges In Immunotherapy For Aml
2023
NKG2D CAR-T cell therapy in AML/MDS 2:00
Nkg2d Car-t Cell Therapy In Aml/mds
2021
Challenges to Overcome With CAR T-Cell Therapy for Acute Myeloid Leukemia 1:29
Challenges To Overcome With Car T-cell Therapy For Acute Mye...
2018
Challenges with CAR-T therapy in AML & insights into IF-BETTER-gated CAR-T cells 2:08
Challenges With Car-t Therapy In Aml & Insights Into If-bett...
2023
Can we target AML with CAR T-cells? 1:37
Can We Target Aml With Car T-cells?
2017
Engineering multi-antigenic CAR T-cells for AML 2:03
Engineering Multi-antigenic Car T-cells For Aml
2021
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.